The complement factor C5a receptor is upregulated in NFL-/- mouse motor neurons

Journal of Neuroimmunology

Volumn 210, Issue 1-2, 2009, Pages 52-62

  Humayun, Saima ^a,b   Gohar, May ^b   Volkening, Kathryn ^b   Moisse, Katie ^a,b   Leystra Lantz, Cheryl ^b   Mepham, Jennifer ^b   McLean, Jesse ^c   Strong, Michael J ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amyotrophic lateral sclerosis; C5aR; Complement; Excitotoxicity; Glutamate; Neurofilament

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A RECEPTOR; GLUTAMIC ACID; KAINIC ACID; NEUROTOXIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CONTROLLED STUDY; EXCITOTOXICITY; IN VITRO STUDY; MALE; MOTONEURON; MOUSE; NERVE CELL LESION; NEUROFILAMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD NERVE CELL; UPREGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; KAINIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR NEURON DISEASE; MOTOR NEURONS; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; NEUROTOXINS; RECEPTOR, ANAPHYLATOXIN C5A; UP-REGULATION;

EID: 67349192161     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.01.028     Document Type: Article

References (54)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S.T., Hampel H., Hull M., Landreth G., Lue L.-F., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Alexianu M.E., Kozovska M., and Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57 (2001) 1282-1289
3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., and Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 (2006) 602-611
4. Armstrong R.C., Harvath L., and Dubois-Dalcq M.E. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 27 (1990) 400-407
5. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M., and Percy M.E. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53 (1994) 221-230
6. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillée S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.-P., Goldstein L.S.B., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
7. Elliott J.L. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Mol. Brain Res. 95 (2001) 172-178
8. Farkas I., Baranyi L., Liposits Z.S., Yamamoto T., and Okada H. Complement C5A anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience 86 (1998) 903-911
9. Farkas I., Baranyi L., Takahashi M., Fukuka A., Liposits Z.S., Yamamoto T., and Okada H. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J. Physiol. 507 (1998) 679-687
10. Farkas I., Baranyi L., Kaneko Y., Liposits Z., Yamamoto T., and Okada H. C5a receptor expression by TGW neuroblastoma cells. NeuroReport 10 (1999) 3021-3025
11. Ferraiuolo L., Heath P.R., Holden H., Kasher P., Kirby J., and Shaw P.J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. 27 (2007) 9201-9219
12. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Götze O., and Morgan B.P. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155 (1995) 4882-4889
13. Gasque P., Dean Y.D., McGreal E.P., VanBeek J., and Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49 (2000) 171-186
14. Gerard C., and Gerard N.P. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12 (1994) 775-808
15. He B.P., Wen W., and Strong M.J. Activated microglia (BV-2) facilitation of TNF-mediated motor neuron death in vitro. J. Neuroimmunol. 128 (2002) 31-38
16. Henkel J.S., Engelhardt J.I., Siklos L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., and Appel S. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis. Ann. Neurol. 55 (2005) 221-235
17. Hensley K., Floyd R.A., Gordon B., Mou S., Pye Q.N., Stewart C., West M., and Williamson K. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G39A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 82 (2002) 365-374
18. Hensley K., Fedynyshyn J., Ferrell S., Floyd R.A., Gordon B., Grammas P., Hamdheydari L., Mhatre M., Shenyu M., Pye Q.N., Stewart C., West M., West S., and Williamson K.S. Message and protein-level elevation of tumor necrosis factor α (TNFα) and TNFα-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 14 (2003) 74-80
19. Kaczorowski S.L., Schiding J.K., Toth C.A., and Kochanek P.M. Effect of soluble complement receptor-1 on neurotrophil accumulation after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 15 (1995) 860-864
20. Lacy M., Jones J., Whittemore S.R., Haviland D.L., Wetsel R.A., and Barnum S.R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61 (1995) 71-78
21. McLean J.R., Leystra-Lantz C., He B.P., and Strong M.J. Temporal profiles of neuronal degeneration, glial proliferation, and cell death in hNFL+/+ and NFL-/- mice. Glia 52 (2005) 59-69
22. Menzies F.M., Grierson A.J., Cookson M.R., Heath P.R., Tomkins J., Figlewicz D.A., Ince P.G., and Shaw P.J. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J. Neurochem. 82 (2002) 1118-1128
23. Moisse K., and Strong M.J. Innate immunity in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762 (2006) 1083-1093
24. Morgan E.L., Ember J.A., Sanderson S.D., Scholz W., Buchner R., Ye R.D., and Hugli T.E. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. J. Immunol. 151 (1993) 377-388
25. Morgan B.P., Griffiths M., Khanom H., Taylor S.M., and Neal J.W. Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats. Clin. Exp. Immunol. 138 (2004) 430-438
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
27. Müller-Ladner U., Jones J.L., Wetsel R.A., Gay S., Raine C.S., and Barnum S.R. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 144 (1996) 135-141
28. Nataf S., Davoust N., and Barnum S.R. Kinetics of analphylatoxin C5a receptor expression during experimental allergic encephalomyelitis. J. Neuroimmunol. 91 (1998) 147-155
29. Nataf S., Stahel P.F., Davoust N., and Barnum S.R. Complement anaphylatoxin receptors on neurons: new tricks for old receptors?. Trends Neurosci. 22 (1999) 397-402
30. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., and Lee V.M.Y. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
31. O'Barr S.A., Caguioa J., Gruol D., Perkins G., Ember J.A., Hugli T., and Cooper N.R. Neuronal expression of a functional receptor for the C5a complement activation fragment. J. Immunol. 166 (2001) 4154-4162
32. Osaka H., McGinty A., Höepken U.E., Lu B., Gerard C., and Pasinetti G.M. Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience 88 (1999) 1073-1082
33. Osaka H., Mukherjee P., Aisen P.S., and Pasinetti G.M. Complement-derived anaphylatoxin C5a protects against glutamate mediated neurotoxicity. J. Cell. Biochem. 73 (1999) 303-311
34. Pasinetti G.M., Tocco C., Sakhi S., Musleh W.D., DeSimoni M.G., Mascarucci P., Schreiber S., Baudry M., and Finch C.E. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative response that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol. Dis. 3 (1996) 197-204
35. Poloni M., Facchetti D., Mai R., Micheli A., Agnoletti L., Francolini G., Mora G., Camana C., Mazzini L., and Bachetti T. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 287 (2000) 211-214
36. Reiman R., Gerard C., Campbell I.L., and Barnum S.R. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis. Eur. J. Immunol. 32 (2002) 1157-1163
37. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P., and Lieberburg I. Complement activation by b-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10016-10020
38. Sanelli T., Ge W., Leystra-Lantz C., and Strong M.J. Calcium mediated excitotoxicity in neurofilament aggregate bearing neurons in vitro is NMDA receptor dependant. J. Neurol. Sci. 256 (2007) 39-51
39. Sayah S., Patte C., Gasque P., Chan P., Ischenko A., Vaudry H., and Fontaine M. Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Mol. Brain Res. 48 (1997) 215-222
40. Stahel P.F., and Barnum S.R. Bacterial meningitis: complement gene expression in the central nervous system. Immunopharmacology 38 (1997) 65-72
41. Stahel P.F., Frei K., Eugster H.-P., Fontana A., Hummel K.M., Wetsel R.A., Ames R.S., and Barnum S.R. TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria menijngoencephalitis. J. Immunol. 159 (1997) 861-869
42. Stahel P.F., Kossmann T., Morganti-Kossmann M.C., Hans V.H.J., and Barnum S.R. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Mol. Brain Res. 50 (1997) 205-212
43. Stahel P.F., Kariya K., Shohami E., Barnum S.R., Eugster H.-P., Trentz O., Kossmann T., and Morganti-Kossmann M.C. Intracerebral complement C5a receptor (CD88)expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice. J. Neuroimmunol. 109 (2000) 164-172
44. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J. Neuropathol. Exp. Neurol. 64 (2005) 649-664
45. Strong M.J., Volkening K., Hammond R., Yang W., Strong W.L., Leystra-Lantz C., and Shoesmith C. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 35 (2007) 320-327
46. van Beek J., Elward K., and Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N.Y. Acad. Sci. 992 (2003) 56-71
47. Wen W., Sanelli T., Ge W., Strong W.L., and Strong M.J. Activated microglial supernatant induced motor neuron cytotoxicity is associated with upregulation of the TNFR1 receptor. Neurosci. Res. 55 (2006) 87-95
48. Williams C.A., Schupf N., and Hugli T.E. Anaphylatoxin C5a modulation of the alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9 (1985) 29-40
49. Wong N., He B.P., and Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol. 59 (2000) 972-982
50. Woodruff T.M., Costantini K.J., Crane J.W., Atkin J.D., Monk P.N., Taylor S.M., and noakes P.G. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J. Immunol. 181 (2008) 8727-8734
51. Yamada T., McGeer P.L., and McGeer E.G. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol. 84 (1992) 100-104
52. Yao J., Harvath L., Gilbert D.L., and Colton C.A. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27 (1990) 36-42
53. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J.-I., Takeuchi H., Doyu M., and Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80 (2002) 158-167
54. Zhao W., Xie W., Le W., Beers D.R., He Y., Henkel J.S., Simpson E.P., Yen A.A., Xiao Q., and Appel S.H. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J. Neuropathol. Exp. Neurol. 63 (2004) 964-977